Is this good? Have to wait until tomorrow to actually speak to someone.
Peripheral blood, flow cytometric immunophenotyping:
Normal immunophenotyping results. No monotypic B-cell population identified.
Comment:
Minimal residual disease (MRD) analysis is intended to detect small clonal
populations of residual chronic lymphocytic leukemia (CLL) cells following
chemotherapy or bone marrow transplantation. This CLL MRD assay is validated
to a sensitivity level of 0.01%, or 1 in 10,000 white blood cells.
Special Studies
Your Value
WBC: 3.2 x 10(9)/L
%Lymphs (CBC/automated differential): 26%
#Lymphs (CBC/automated differential): 0.8 x 10(9)/L
Result
B-cells: No monotypic, MRD negative; normal pattern of expression of CD19,
CD20, CD5, CD23, CD38, CD45, surface and cytoplasmic kappa and lambda.
Quality Assessment: Specimen received within validated guidelines.
Microscopic Description
Your Value
A Wright-Giemsa-stained slide prepared from the flow cytometry specimen is
examined. No morphologic features of acute leukemia or ly